Results 241 to 250 of about 11,975,902 (386)

Oral Solid Dosage Form Disintegration Testing - The Forgotten Test.

Journal of Pharmacy and Science, 2015
J. Al-Gousous, P. Langguth
semanticscholar   +1 more source

Real‐World Investigation of Satralizumab in Patients With Neuromyelitis Optica Spectrum Disease

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Satralizumab, a monoclonal antibody targeting the interleukin‐6 receptor, has demonstrated efficacy in clinical trials for neuromyelitis optica spectrum disorder (NMOSD). However, its real‐world effectiveness and safety compared to conventional immunosuppressive therapies remain uncertain.
Li‐Tsung Lin, Hui‐An Lin, Sheng‐Feng Lin   +2 more
wiley   +1 more source

Kinetic Spectrophotometric Determination Of Ramipril In Commercial Dosage Forms

, 2008
Nafisur Rahman, Habibur Rahman, Syed Najmul Hejaz Azmi   +2 more
openalex   +1 more source

Spectrophotometric methods for simultaneous determination of Carvedilol and Hydrochlorothiazide in combined dosage form

, 2016
N. Abdelwahab
semanticscholar   +1 more source

A review of polymers as multifunctional excipients in drug dosage form technology

Saudi Pharmaceutical Journal, 2015
B. Karolewicz
semanticscholar   +1 more source

Inhibition of Classical and Alternative Complement Pathway by Ravulizumab and Eculizumab

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To explore the feasibility of classical (CH50) and alternative (AH50) complement pathway activity as potential biomarkers for treatment guidance and monitoring during therapy with ravulizumab in patients with generalized myasthenia gravis (gMG) and compare these to therapeutic drug monitoring under eculizumab.
Lea Gerischer, Frauke Stascheit, Maximilian Mönch, Paolo Doksani, Carla Dusemund, Meret Herdick, Philipp Mergenthaler, Maike Stein, Amani Suboh, Jutta Schröder‐Braunstein, Guido Wabnitz, Jan D. Lünemann, Sophie Lehnerer, Sarah Hoffmann, Andreas Meisel   +14 more
wiley   +1 more source

Development and validation of a novel fluorometric approach utilizing flow injection analysis for the measurement of vilazodone: application to dosage form and spiked human plasma. [PDF]

BMC Chem
Zaafan AAS, Derayea SM, Oraby M, Nagy DM.   +3 more
europepmc   +1 more source

Development of gastroretentive dosage form

European Journal of Pharmaceutical Sciences, 1996
Whitehead, L, Fell, JT, Collett, JH.
openaire   +2 more sources

Changes in Immune‐Inflammation Status and Acute Ischemic Stroke Prognosis in Prospective Cohort

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Inflammation is a critical risk factor for poor outcomes in cerebral infarction. Prior studies focused primarily on baseline inflammation status, neglecting dynamic longitudinal changes. We try to investigate the association between immune‐inflammation status alterations and stroke prognosis, and evaluated three systemic biomarkers'
Songfang Chen, Wenting Huang, Yitian Liu, Xuan Chen, Buyu Ke, Qian Shen, Hanyu Cai, Jing Sun, Yan Li, Yungang Cao, Beilei Hu, Keyang Chen   +11 more
wiley   +1 more source

Development of UV-Chemometric techniques for resolving the overlapped spectra of aspirin, caffeine and orphenadrine citrate in their combined pharmaceutical dosage form. [PDF]

BMC Chem
El-Adl SM, Mattar AA, El-Abassy OM, Sebaiy MM.   +3 more
europepmc   +1 more source